United Kingdom Paroxysmal Supraventricular Tachycardia Market Research Report (2025) By Leading Players, Emerging Technologies, Opportunity 2032shivani11 min read·Just nowJust now--Press enter or click to view image in full size“What is the current size and growth rate of the Paroxysmal Supraventricular Tachycardia Market?The global Paroxysmal Supraventricular Tachycardia Market was valued at USD 1.35 billion in 2024.It is projected to achieve a market valuation of USD 2.12 billion by 2032, exhibiting a Com ...

上海活动报名： 2025医疗器械研发创新论坛 2025年9月17日， Vivani Medical 宣布已确定其 子公司 Cortigent 的分拆登记日 。根据安排，10月8日持 有公司普通股的股东将获得 Cortigent 的普通股，该公司预计将在纳斯达克以"CRGT"代码独立交易。此次分 拆标志着 Vivani 将形成"两条主线"： 一方面继续专注于微型药物植入技术，另一方面由 Cortigent 独立推进 神经植入与脑机接口产品 。 一、Vivani 拆分 Cortigent Vivani 于2025年5月 首次披露 分拆计划，并在9月确认了登记日。根据公告， 股东将按照持股比例直接获得 Cortigent 的股份 ， 预计交易将在2025年底前完成 。分拆完成后，Vivani 与 Cortigent 将分别聚焦各自的 业务领域：Vivani 致力于药物递送植入装置，而 Cortigent 将专注于神经调控和脑机接口技术。 Vivani CEO Adam Mendelsohn 表示，此次交易的战略目标是建立两家在各自领域中能够独立创造价值的公 司。公司管理层认为，分拆后各方能够获得更大的战略灵活度、资 ...

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST). Shareholders who purchased shares of RXST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/rxsight-inc-loss-submission-form/?id=167835&from=3  CLASS PERIOD: November 7, 2024 ...

DIH Receives Notice of Additional Basis for Delisting from The Nasdaq Stock Market DIH Has Requested Hearing to Appeal before Nasdaq Hearing Panel NORWELL, Mass., Sept. 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) received a notice on September 12, 2025, from the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the “Bid Price Rule”) and, accordingly, th ...

In this article, we will take a look at some of the best options for a dividend stock portfolio.Dividends have long been a magnet for investors. A Wall Street Journal report noted that many shareholders said they didn’t rely on dividend income right now but believed dividend-paying stocks tend to offer stronger returns with lower volatility.History backs up that view. Research from Ned Davis covering the past 50 years shows that S&P 500 companies paying dividends delivered annualized returns of 9.2%, more t ...

Healthcare payment concept with stethoscope and big money US dollar.gettyMost Wall Street “suits” are allergic to dividend cuts. These spreadsheet jockeys sooooo lack imagination. They prefer linear trends—up and to the right.Dividend growers model nicely. Payout “resets” (cuts!) do not. So, there is often a knee-jerk reaction from analysts to sell every divvie slash they see.Same goes for most individual income investors. These vanilla beans sold BlackRock Health Sciences Term Trust (BMEZ) late last week w ...

NEW YORK and NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into iRhythm Technologies, Inc. (NasdaqGS: IRTC). On May 30, 2023, the Company disclosed the receipt of a Warning Letter from the FDA regarding “non-conformities to regulations for medical devices, including medical device reporting requirements, relating to the Company’s Zio ...

Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts. On September 11, analysts at Needham reiterated a ‘Buy’ rating on the stock and a $121 price target. The positive stance comes as the company plans to launch Bolt’s laser-based intravascular lithotripsy (IVL) system for peripheral use in late 2025. Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity Image: Courtesy of Boston Scientific The company has already c ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of best beginner stocks to buy, according to analysts. On September 4, Bernstein SocGen Group reiterated an ‘Outperform’ rating on the stock and a $685 price target. Intuitive Surgical (ISRG) is an ‘Outperform’ Ahead of Key Product Launches: Bernstein SocGen Group According to the research firm, the stock is currently trading at a discount after pulling back from its high of $610 per share, recorded in January. Consequently, it views the current trading range ...

Key Takeaways SYK partners with Siemens Healthineers to co-develop a robotic neurovascular system.The collaboration integrates robotics, imaging and SYK devices for faster care.SYK aims to enhance workflows, precision and patient outcomes in neurovascular procedures.Stryker (SYK) recently entered into a strategic partnership with Siemens Healthineers to co-develop a first-of-its-kind robotic system for neurovascular procedures. The collaboration is designed to integrate robotics, imaging and Stryker’s neuro ...